Archive

She will be the 20th recipient and the third woman to receive CHF's most coveted award

To advance Adva-27a as a treatment for this deadly form of cancer

ARTERIA aims to transform medical practices in the treatment of heart disease, while realising major savings for the health system…

{source}<div data-configid="5690019/6753883" style="width: 600px; height: 402px;" class="issuuembed"></div><script…

Blogging about her recent trip to India, Margaret Hamburg, Commissioner of the US Food and Drug Administration (FDA) spoke about…

The patents are valid through 2029 and 2030

The Board of Directors of Sun Pharmaceutical Industries have announced the appointment of Rekha Sethi as an additional independent…

Temozolomide capsules are indicated for the treatment of adult patients with newly diagnosed glioblastoma multiforme concomitantly…

New UN report says development gains from the past 20 years cannot be sustained unless governments tackle the inequalities that…

EBITDA has been reported at Rs 1975 crores

Inflectra is the first biosimilar monoclonal antibody to be approved in Europe

Mugyenyi is the Director and Co-Founder of the Joint Clinical Research Centre (JCRC) based in Kampala

With the acquisition of Life Technologies, Thermo Fisher has established a new reporting segment, called Life Sciences Solutions

To develop world-leading mouse clinical centre and largest Annotated PDX and Translational Oncology Platform

The event was inaugurated by Chief Minister of Karnataka, Siddaramaiah

To develop and optimise yeast strains for production of an important cosmetics ingredient Evolva Holding SA (SIX: EVE) announced…

As far as the emerging markets are concerned certain regulatory developments in some of the markets have hindered the growth…

Pro-Ject is a novel auto-injector that has been designed and developed with input from patients and healthcare professionals to…

Unique CRADA adds focus on global inspections, multi-linguality, import/export regulations training, and mobile technology

Exports are likely to overtake domestic market sales in FY15, according to the rating agency